211
[Explainer] why "compounded" does not mean "generic"
Genuinely asking, not being difficult. Everyone in c/hplc repeats that shortage list is important. I believe it, but I have never seen anyone show why, and when I…
u/neha_krastev
Contributes reviews on supplier material. Based in Tilburg.
member · joined 13 Apr 2025
578post karma
2,783comment karma
1submissions
37comments
comment on [Explainer] why "compounded" does not mean "generic" in c/compounding · 6 points · 4 days ago
Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.
comment on [Results] came off deliberately over four months, regained 4kg not 24 in c/tapering · 21 points · 4 days ago
coming off deliberately, not by accident
comment on interval stretching is the most under-discussed thing in c/t2dglp1 in c/tapering · 58 points · 1 months ago
STEP 1 and SURMOUNT-4 discontinuation arms show regain
comment on France: pharmacology, and what it actually costs here in c/glp1science · 54 points · 1 months ago
amylin is not GLP-1, posts conflating them get corrected
comment on tried telehealth for 15 weeks. here is what happened. in c/compounding · 212 points · 1 months ago
no pharmacy referral codes, naming is fine, recruiting is not
comment on someone explain receptor to me like I have not read a paper in years in c/glp1science · 49 points · 1 months ago
Which paper are you quoting?
comment on help me understand incretin, I have read the wiki twice in c/glp1science · 20 points · 2 months ago
do not extrapolate rodent data to human dosing without saying so
comment on receptor — my 19-week log, condensed into one table in c/glp1science · 22 points · 2 months ago
Strongly agree. Central appetite is real but people overstate it.
comment on three years of regain threads, summarised so you do not have to read them in c/tapering · 3 points · 3 months ago
cite the discontinuation data rather than guessing regain rates
comment on ATTAIN — 3 things I got wrong before I got it right in c/orforglipron · 53 points · 3 months ago
Yeah, small molecule changes the whole game.
comment on [Question] 503A — what am I missing here in c/compounding · 5 points · 3 months ago
503B compounding is different from 503A, different rules, different legality
comment on interval stretching — my 5-week log, condensed into one table in c/tapering · 22 points · 4 months ago
say how long you were on and at what dose before taper
comment on Germany: discontinuation, and what it actually costs here in c/tapering · 29 points · 4 months ago
regain on taper is expected, plan for it
comment on why does nobody talk about shortage list in c/compounding · 4 points · 5 months ago
API transparency is the question that separates good compounders from sketchy ones
comment on what changed for me between week 20 and week 63 in c/compounding · 424 points · 6 months ago
503B compounding is different from 503A, different rules, different legality
comment on the ACHIEVE question that gets asked weekly, answered properly in c/orforglipron · 18 points · 6 months ago
no cold chain means oral GLP-1, if approved
comment on [Discussion] we are measuring 503A at the wrong time and calling it noise in c/compounding · 20 points · 7 months ago
the 503A/503B distinction is load-bearing, do not blur it
comment on tried gastric emptying for 14 weeks. here is what happened. in c/glp1science · 70 points · 10 months ago
wrong community but useful, so, shrug
comment on [Discussion] the small molecule advice in here is 19 years out of date in c/orforglipron · 4 points · 11 months ago
oral non-peptide agonist is non-peptide, no food restrictions